Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06247813 · ClinicalTrials.gov registry record · Phase 2

Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain

A Phase 2 study of Chronic Pain, sponsored by Ethos Research & Development.

Recruiting
Registry status
Phase 2
Development phase
75
Enrollment target
1
Study location

NCT06247813 is a Phase 2 study of Chronic Pain that is actively recruiting participants, run by Ethos Research & Development. The registered enrollment target is 75 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06247813, a Phase 2 study of Chronic Pain, is actively recruiting participants, sponsored by Ethos Research & Development.

RECRUITING
Registry status
Phase 2
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to use pain-specific urine biomarkers to evaluate how daily nutritional supplementation with biomarker guided formulas effect, quality of life and urinary biomarker scores in chronic pain patients. Assessing the effect of biomarker guided supplementation on pain specific biomarkers through changes in urinary biomarker scores may solidify the necessity for identifying deficiencies to create an individualized treatment plan for pain patients. This study aims to evaluate the effect of biomarker-guided supplementation on the three categories of urinary biomarkers using targeted ingredients specifically designed for oxidative stress, inflammation, and nerve health. This study provides subjects with one of three nutritional supplement formulas based on their specific urinary biomarker test results and assesses changes in their urinary biomarker levels and their quality of life as it relates to their pain over a 3-month period.

Conditions Studied

Chronic Pain

Interventions

  • DIETARY_SUPPLEMENT Inflammation Support Formula
  • DIETARY_SUPPLEMENT Nerve Health Formula
  • DIETARY_SUPPLEMENT Redox Support Formula

Study Locations (1)

Kentucky

  • Ethos Research and Development - Newport

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2024-02-08
Est. Completion 2025-07-30
Phase Phase 2

Sponsor

Ethos Research & Development

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06247813

The ClinicalTrials.gov registry entry for NCT06247813 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (90% lower). The listed sponsor is Ethos Research & Development, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 3 interventions - of which Inflammation Support Formula is the first listed.

NCT06247813 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT06247813 about?

NCT06247813 is a clinical study titled "Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain". The goal of this study is to use pain-specific urine biomarkers to evaluate how daily nutritional supplementation with biomarker guided formulas effect, quality of life and urinary biomarker scores in chronic pain patients. Assessing the effect of biomarker guided supplementation on pain specific bi...

What is the current status of trial NCT06247813?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2024-02-08. Estimated completion is 2025-07-30.

What conditions does trial NCT06247813 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT06247813?

The interventions under investigation include: Inflammation Support Formula (DIETARY_SUPPLEMENT), Nerve Health Formula (DIETARY_SUPPLEMENT), Redox Support Formula (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06247813?

This trial is sponsored by Ethos Research & Development, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06247813 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Pain

All registered trials for this condition

Kentucky

All trials with a study site in Kentucky

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.